Graham Dixon – Chief Scientific Officer

Dr Graham Dixon has a 27 year international career in the pharmaceutical industry, with a strong track record in R&D across many therapeutic areas.  He also has solid leadership experience having worked across a number of R&D management positions at AstraZeneca plc and in C-level management positions in several biotech companies:  Entomed SA;  Galapagos NV (AMS:GLPG);  Addex Therapeutics SA (SWX:ADXN);  Sensorion SA (EPA:ALSEN) and Onxeo SA (EPA:ONXEO).

Dr Dixon has also held leadership roles in successful programmes spanning the whole continuum of R&D, including clinical proof-of-concepts and regulatory approvals. On the business side, he has held executive roles in two successful IPOs (Galapagos & Sensorion) and 10 clinical stage licensing deals.

He has also held several non-executive director positions in the biotech sector and acted as an advisor to several venture capital organisations and their portfolio companies. Dr Dixon obtained a Bachelor’s degree in Biology from the University of Bradford, UK and a PhD in Biochemistry from the University of Swansea, UK.